Search results for "Radiotherapy Dosage"

showing 10 items of 73 documents

Brachytherapy organ dose estimation using Monte Carlo simulations of realistic patient models

2018

Radiation Therapy Planning Systems (RTPS) currently used in hospitals contain algorithms based on deterministic simplifications that do not properly consider electrons lateral transport in the areas where there are changes of density, and as a result, erroneous dose predictions could be produced. According to this, the present work proposes the use of Monte Carlo method in brachytherapy planning systems, which could affect positively on the radiotherapy treatment planning, since it provides results that are more accurate and takes into account the in homogeneities density variations. This paper presents a Monte Carlo (MC) simulation of a brachytherapy prostate treatment with I-125 seeds, us…

Malemedicine.diagnostic_testComputer scienceRadiotherapy Planning Computer-Assistedmedicine.medical_treatmentBrachytherapyMonte Carlo methodBrachytherapyRadiotherapy DosageComputed tomographyRadiotherapy treatment planningBrachytherapy prostateIodine RadioisotopesDose estimationmedicineHumansSegmentationRadiation treatment planningMonte Carlo MethodAlgorithmAlgorithms2018 40th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC)
researchProduct

Chemoradioimmunotherapy with 5-fluorouracil, cisplatin and interferon-α in pancreatic and periampullary cancer: Results of a feasibility study

2008

Abstract Background Recent studies give rise to the hypothesis, that adjuvant chemoradioimmunotherapy with 5-fluorouracil (5-FU), cisplatin and interferon-α (IFN-α) might be a possible new treatment of pancreatic cancer in resected patients. We report the up-to-now experience at our institution. Patients and methods Eleven patients with histological diagnosis of localized carcinoma of the pancreas ( n  = 7) or periampullary ( n  = 4) were prospectively analyzed. Four patients were deemed unresectable because of local invasion of adjacent organs (neoadjuvant setting) and seven patients underwent curative resection (adjuvant setting). Eight patients were classified as T3 carcinomas and three …

Malemedicine.medical_specialtyPancreatic diseasemedicine.medical_treatmentAntineoplastic AgentsRisk AssessmentGastroenterology03 medical and health sciences0302 clinical medicineInternal medicinePancreatic cancermedicinePeriampullary cancerHumansNeoplasm InvasivenessRadiology Nuclear Medicine and imagingSurvival rateNeoplasm Staging030304 developmental biology0303 health sciencesbusiness.industryPatient SelectionRadiotherapy Dosagemedicine.diseaseCombined Modality Therapypeople.cause_of_deathRecombinant Proteins3. Good healthSurgeryPancreatic NeoplasmsSurvival RateRadiation therapyOncology030220 oncology & carcinogenesisConcomitantInterferon Type IFeasibility StudiesFemaleFluorouracilImmunotherapyCisplatinbusinesspeopleChemoradiotherapyProgressive diseaseCancer/Radiothérapie
researchProduct

Dose–volume-related dysphagia after constrictor muscles definition in head and neck cancer intensity-modulated radiation treatment

2014

Dysphagia remains a side effect influencing the quality of life of patients with head and neck cancer (HNC) after radiotherapy. We evaluated the relationship between planned dose involvement and acute and late dysphagia in patients with HNC treated with intensity-modulated radiation therapy (IMRT), after a recontouring of constrictor muscles (PCs) and the cricopharyngeal muscle (CM).Between December 2011 and December 2013, 56 patients with histologically proven HNC were treated with IMRT or volumetric-modulated arc therapy. The PCs and CM were recontoured. Correlations between acute and late toxicity and dosimetric parameters were evaluated. End points were analysed using univariate logisti…

Malemedicine.medical_specialtySide effectmedicine.medical_treatmentYoung AdultPlanned DoseSwallowingNuclear Medicine and ImagingIntensity-Modulated80 and overotorhinolaryngologic diseasesHumansMedicineRadiology Nuclear Medicine and imagingTomographyAgedRetrospective StudiesAged 80 and overFull PaperAged; Aged 80 and over; Deglutition; Deglutition Disorders; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Laryngeal Muscles; Male; Middle Aged; Quality of Life; Radiotherapy Dosage; Radiotherapy Intensity-Modulated; Retrospective Studies; Tomography X-Ray Computed; Young Adult; Radiology Nuclear Medicine and ImagingRadiotherapybusiness.industryHead and neck cancerRadiotherapy DosageRetrospective cohort studyGeneral MedicineMiddle Agedmedicine.diseaseDysphagiaAcute toxicityDeglutitionX-Ray ComputedSurgeryRadiation therapyHead and Neck NeoplasmsQuality of LifeFemaleRadiotherapy Intensity-ModulatedRadiologyLaryngeal Musclesmedicine.symptomTomography X-Ray ComputedDeglutition DisordersRadiologybusinessFollow-Up StudiesThe British Journal of Radiology
researchProduct

Extent of Surgery in Rhabdomyosarcoma of Urogenital Structures

1989

After high inguinal semicastration in group-1 paratesticular rhabdomyosarcoma (RMS), the patient having undergone chemotherapy can be followed closely by CT scanning without retroperitoneal lymphadenectomy. In contrast, retroperitoneal RMS should be operated on as radically as possible after downstaging the tumor mass. In RMS of the female genitalia locally limited organ-preserving surgery is the method of choice. The prognosis is excellent with adjuvant chemotherapy. Only 20% of all bladder RMS arise from the bladder dome or the movable part of the bladder, where primary partial resection including a safety margin of 3 cm of healthy tissue is possible. The majority, however, arising from t…

Malemedicine.medical_specialtyUrologymedicine.medical_treatmentProstatic urethraAntineoplastic Combined Chemotherapy ProtocolsRhabdomyosarcomamedicineHumansChildRhabdomyosarcomaUpper urinary tractGenitourinary systembusiness.industryUrinary diversionRadiotherapy DosagePrognosismedicine.diseaseCombined Modality TherapySurgeryNeck of urinary bladdermedicine.anatomical_structureFemalebusinessContinent Urinary DiversionUrogenital NeoplasmsChemoradiotherapyFollow-Up StudiesEuropean Urology
researchProduct

Fibrosarcoma in pediatric patients: Results of the Italian Cooperative Group Studies (1979-1995)

2001

Background and Objectives Fibrosarcoma is a rare soft tissue sarcoma (STS) that has two peaks of incidence in pediatric patients: one in infants and young childern (infantile fibrosarcoma), another in older children (“adult type” fibrosarcoma). The purpose of this study was to describe the clinical features and the treatment results in patients affected by fibrosarcoma enrolled in two consecutive studies run by the STS-Italian Cooperative Group (ICG) between 1979 and 1995. Patients and Methods Twenty-five evaluable patients were grouped according the intergroup rhabdomyosarcoma staging (IRS) system: 12 Gr I, 5 Gr II, 8 Gr III. The cut-off point between the two forms was considered the age o…

Malemedicine.medical_specialtyinfantile fibrosarcomaAdolescentmedicine.medical_treatmentSoft Tissue NeoplasmsSettore MED/38 - Pediatria Generale E SpecialisticamedicineHumansFibrosarcomaRhabdomyosarcomaChildSurvival analysisfibrosarcoma; infantile fibrosarcoma; soft tissue sarcomabusiness.industrySoft tissue sarcomaSettore MED/20 - Chirurgia Pediatrica E InfantileAge FactorsInfantRadiotherapy DosageSarcomaGeneral Medicinemedicine.diseaseCombined Modality TherapySurvival AnalysisSurgeryRadiation therapyTreatment OutcomeOncologyChild Preschoolsoft tissue sarcomaSurgeryFemalefibrosarcomaSarcomaInfantile FibrosarcomabusinessProgressive disease
researchProduct

Local and systemic risk factors influencing the long-term success of angular stable alloplastic reconstruction plates of the mandible

2013

Introduction: After ablative surgery of the mandible, angular stable alloplastic reconstruction plates are commonly employed. The aim of the study was a long-term evaluation of local anatomical, as looking at systemic factors influencing specific complications and the failure rate of such plates. Materials and methods: In a retrospective study covering an 11-year period, we reviewed the outcomes of angular stable plates of patients who had a segmental resection of the mandible and subsequent alloplastic reconstruction. Complications and failure rates were assessed and local (anatomical size and localization of resection) as well as systemic risk factors (age, sex, radiation therapy, smoking…

Malemedicine.medical_specialtymedicine.medical_treatmentBone ScrewsBiocompatible MaterialsDehiscenceCumulative survivalCohort StudiesSex FactorsRisk FactorsSurgical Wound DehiscencemedicineHumansLongitudinal StudiesRisk factorDevice RemovalAgedRetrospective StudiesTitaniumbusiness.industrySmokingAge FactorsMandibleRadiotherapy DosageRetrospective cohort studyMiddle AgedSurvival AnalysisSurgeryRadiation therapyMandibular NeoplasmsTreatment OutcomeOtorhinolaryngologyCarcinoma Squamous CellEquipment FailureFemaleSurgeryMandibular ReconstructionOral SurgerySegmental resectionComplicationbusinessBone PlatesFollow-Up StudiesJournal of Cranio-Maxillofacial Surgery
researchProduct

Is high dose rate brachytherapy reliable and effective treatment for prostate cancer patients? A review of the literature.

2014

The intrinsic physical and radiobiological characteristics of High Dose Rate Brachytherapy (HDR-BT) are well suited to the treatment of prostate cancer. HDR-BT was initially used as a boost to external beam brachytherapy, but has subsequently been employed as the sole treatment, which is termed HDR monotherapy. This review summarizes the clinical outcomes and toxicity results of the principal studies and discusses the radiobiological basis supporting its use.

Malemedicine.medical_specialtymedicine.medical_treatmentBrachytherapyBrachytherapyProstate cancermedicineEffective treatmentHumansMedical physicsDose FractionationSalvage brachytherapySalvage TherapyProstate cancerbusiness.industryRadiobiologyProstatic NeoplasmsRadiotherapy DosageHDR-BTHematologymedicine.diseaseBrachytherapy boost; HDR-BT; High-dose rate brachytherapy; Prostate cancer; Radiobiology; Salvage brachytherapy; Dose Fractionation; Humans; Male; Prostatic Neoplasms; Salvage Therapy; Treatment Outcome; Brachytherapy; Radiotherapy Dosage; Hematology; Oncology; Geriatrics and GerontologyHigh-Dose Rate BrachytherapyBrachytherapy boostTreatment OutcomeOncologyRadiologyDose Fractionation RadiationGeriatrics and GerontologybusinessHigh-dose rate brachytherapySalvage brachytherapyCritical reviews in oncology/hematology
researchProduct

Multiparametric MRI and post implant CT-based dosimetry after prostate brachytherapy with iodine seeds: The higher the dose to the dominant index les…

2015

Abstract Purpose To determine whether post-implant MRI-based dosimetry of the Dominant Intra-prostatic Lesion (DIL) could best predict the occurrence of PSA bounce after prostate brachytherapy. Methods and materials We selected 66 patients with a low risk prostate cancer treated with 125 I prostate brachytherapy as monotherapy. Post-implant dosimetry based on day 30 CT-scan and multiparametric MRI co-registration was generated: planned D 90, D 95, V 100, V 150 values were calculated for each DIL. Bounce was defined as a PSA elevation ⩾0.2ng/mL from the previous baseline value followed by a decrease to or below the prior nadir with no additional treatment. Results After a median follow-up of…

Malemedicine.medical_treatmentBrachytherapyBrachytherapyIodine RadioisotopesProstate cancerProstatemedicineHumansDosimetryRadiology Nuclear Medicine and imagingRadiometryAgedRetrospective StudiesIndex Lesionmedicine.diagnostic_testbusiness.industryProstateProstatic NeoplasmsRadiotherapy DosageMagnetic resonance imagingHematologyMiddle AgedProstate-Specific Antigenmedicine.diseaseMagnetic Resonance ImagingProstate-specific antigenTreatment Outcomemedicine.anatomical_structureOncologyTomography X-Ray ComputedNuclear medicinebusinessProstate brachytherapyFollow-Up StudiesRadiotherapy and Oncology
researchProduct

Prediction of Normal Organ Absorbed Doses for [177Lu]Lu-PSMA-617 Using [44Sc]Sc-PSMA-617 Pharmacokinetics in Patients With Metastatic Castration Resi…

2018

In vivo pharmacokinetic analysis of [Sc]Sc-PSMA-617 was used to determine the normal organ-absorbed doses that may result from therapeutic activity of [Lu]Lu-PSMA-617 and to predict the maximum permissible activity of [Lu]Lu-PSMA-617 for patients with metastatic castration-resistant prostate carcinoma. Methods Pharmacokinetics of [Sc]Sc-PSMA-617 was evaluated in 5 patients with metastatic castration-resistant prostate carcinoma using dynamic PET/CT, followed by 3 static PET/CT acquisitions and blood sample collection over 19.5 hours, as well as urine sample collection at 2 time points. Total activity measured in source organs by PET imaging, as well as counts per milliliter measured in bloo…

Malemedicine.medical_treatmentUrineLutetiumRadiation Dosageurologic and male genital diseases030218 nuclear medicine & medical imagingCastration-Resistant Prostate CarcinomaHeterocyclic Compounds 1-Ring03 medical and health sciences0302 clinical medicinePharmacokineticsIn vivoPositron Emission Tomography Computed TomographyOrganometallic CompoundsmedicineHumansRadiology Nuclear Medicine and imagingExternal beam radiotherapyNeoplasm MetastasisAgedUrinary bladderbusiness.industryRadiotherapy Planning Computer-AssistedCarcinomaRadiotherapy DosageDipeptidesGeneral MedicineProstate-Specific AntigenProstatic Neoplasms Castration-Resistantmedicine.anatomical_structure030220 oncology & carcinogenesisSample collectionBone marrowRadiopharmaceuticalsbusinessNuclear medicineScandiumClinical Nuclear Medicine
researchProduct

Interactive multiobjective optimization for anatomy-based three-dimensional HDR brachytherapy.

2010

In this paper, we present an anatomy-based three-dimensional dose optimization approach for HDR brachytherapy using interactive multiobjective optimization (IMOO). In brachytherapy, the goals are to irradiate a tumor without causing damage to healthy tissue. These goals are often conflicting, i.e. when one target is optimized the other will suffer, and the solution is a compromise between them. IMOO is capable of handling multiple and strongly conflicting objectives in a convenient way. With the IMOO approach, a treatment planner’s knowledge is used to direct the optimization process. Thus, the weaknesses of widely used optimization techniques (e.g. defining weights, computational burden an…

MatematikMathematical optimizationOptimization problemModels StatisticalRadiological and Ultrasound TechnologyProcess (engineering)Computer scienceComputersmedicine.medical_treatmentRadiotherapy Planning Computer-AssistedBrachytherapyBrachytherapyReproducibility of ResultsUterine Cervical NeoplasmsRadiotherapy DosageAnatomyMulti-objective optimizationImaging Three-DimensionalmedicineHumansRadiology Nuclear Medicine and imagingFemaleMathematicsAlgorithmsSoftwarePhysics in medicine and biology
researchProduct